FREQUENCY THERAPEUTICS INC (FREQ) Stock Price, Quote, News and Overview
NASDAQ:FREQ - Nasdaq - US35803L1089 - Common Stock - Currency: USD
FREQ Quote, Performance and Key Statistics
NASDAQ:FREQ (11/3/2023, 8:00:00 PM)
0.2996
+0.02 (+5.94%)
The current stock price of FREQ is 0.2996 USD. In the past month the price decreased by -0.1%. In the past year, price decreased by -87.52%.
FREQ Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About FREQ
Company Profile
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person’s innate regenerative potential to restore function. The company is headquartered in Lexington, Massachusetts and currently employs 48 full-time employees. The company went IPO on 2019-10-03. The Company, using its progenitor cell activation (PCA) platform, is developing its lead product candidate, FX-322, for the treatment of sensorineural hearing loss (SNHL). FX-322 is designed to treat the underlying cause of SNHL by regenerating hair cells through activation of progenitor cells already present in the cochlea. The firm is also conducting Phase IIb study for the product FX-322. The Company’s SNHL investigational therapeutic program, FX-345, is designed to achieve broader exposure through the cochlea. The Company’s progenitor cell activation (PCA) uses small molecules to activate progenitor cells within the body to create functional tissue.
Company Info
FREQUENCY THERAPEUTICS INC
75 Hayden Avenue, Suite 300
Lexington MASSACHUSETTS 01801 US
CEO: David L. Lucchino
Employees: 48
Company Website: https://www.frequencytx.com/
Phone: 17813154600.0
FREQUENCY THERAPEUTICS INC / FREQ FAQ
What is the stock price of FREQUENCY THERAPEUTICS INC today?
The current stock price of FREQ is 0.2996 USD. The price increased by 5.94% in the last trading session.
What is the ticker symbol for FREQUENCY THERAPEUTICS INC stock?
The exchange symbol of FREQUENCY THERAPEUTICS INC is FREQ and it is listed on the Nasdaq exchange.
On which exchange is FREQ stock listed?
FREQ stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for FREQUENCY THERAPEUTICS INC stock?
6 analysts have analysed FREQ and the average price target is 0.51 USD. This implies a price increase of 70.23% is expected in the next year compared to the current price of 0.2996. Check the FREQUENCY THERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is FREQUENCY THERAPEUTICS INC worth?
FREQUENCY THERAPEUTICS INC (FREQ) has a market capitalization of 11.06M USD. This makes FREQ a Nano Cap stock.
How many employees does FREQUENCY THERAPEUTICS INC have?
FREQUENCY THERAPEUTICS INC (FREQ) currently has 48 employees.
What are the support and resistance levels for FREQUENCY THERAPEUTICS INC (FREQ) stock?
FREQUENCY THERAPEUTICS INC (FREQ) has a resistance level at 0.74. Check the full technical report for a detailed analysis of FREQ support and resistance levels.
Should I buy FREQUENCY THERAPEUTICS INC (FREQ) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of FREQ, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of FREQ, evaluating the profitability, health, valuation and growth aspects
- FREQUENCY THERAPEUTICS INC (FREQ) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- FREQUENCY THERAPEUTICS INC (FREQ) Sales and EPS estimates to see what analysts future expectations are.
- FREQUENCY THERAPEUTICS INC (FREQ) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- FREQUENCY THERAPEUTICS INC (FREQ) Insider and Institutional Ownership to learn about the owners and their transactions.
- FREQUENCY THERAPEUTICS INC (FREQ) Stock Chart to make your own analysis
- FREQUENCY THERAPEUTICS INC (FREQ) Latest news and press-releases to stay up to date.
Does FREQUENCY THERAPEUTICS INC (FREQ) stock pay dividends?
FREQ does not pay a dividend.
When does FREQUENCY THERAPEUTICS INC (FREQ) report earnings?
FREQUENCY THERAPEUTICS INC (FREQ) will report earnings on 2024-03-08, after the market close.
What is the Price/Earnings (PE) ratio of FREQUENCY THERAPEUTICS INC (FREQ)?
FREQUENCY THERAPEUTICS INC (FREQ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.2).
FREQ Technical Analysis
FREQ Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to FREQ. The financial health of FREQ is average, but there are quite some concerns on its profitability.
FREQ Financial Highlights
Over the last trailing twelve months FREQ reported a non-GAAP Earnings per Share(EPS) of -2.2. The EPS increased by 13.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -76.59% | ||
| ROE | -145.99% | ||
| Debt/Equity | 0 |
FREQ Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to FREQ. The Buy consensus is the average rating of analysts ratings from 6 analysts.